Gestational and pregestational diabetes in pregnant women with cystic fibrosis
As cystic fibrosis transmembrane regulator (CFTR) modulator therapies offer greater longevity and improved health quality, women living with cystic fibrosis (CF) are increasingly pursuing pregnancy. Maternal risks for pregnant women with CF largely depend on a woman’s baseline pulmonary and pancreat...
Main Authors: | Rachael Oxman, Andrea H. Roe, Ullal Jagdeesh, Melissa S. Putman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-03-01
|
Series: | Journal of Clinical & Translational Endocrinology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214623721000417 |
Similar Items
-
Insulin aspart in patients with gestational diabetes mellitus and pregestational diabetes mellitus
by: M C Deepaklal, et al.
Published: (2015-01-01) -
Prediction of preeclampsia based on maternal serum endoglin level in women with pregestational diabetes mellitus
by: Roman V. Kapustin, et al.
Published: (2022-10-01) -
Alterations in the Gut Microbiota in Pregnant Women with Pregestational Type 2 Diabetes Mellitus
by: Yuan Ren, et al.
Published: (2023-04-01) -
Overt diabetes imposes a comparable burden on outcomes as pregestational diabetes: a cohort study
by: Maria Lúcia Oppermann, et al.
Published: (2022-11-01) -
Cystic fibrosis related liver disease and endocrine considerations
by: Jordan S. Sherwood, et al.
Published: (2022-03-01)